For example, silencing the NFE2L2 gene increased 5FU sensitization in hepatocellular carcinoma cells [24], RTN4 knockdown promoted higher cytotoxic events in paclitaxel-treated cancer cells [25], and RND3 overexpression promoted drug resistance in gastric cell lines [26]. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.